243 filings
8-K
ENVB
Enveric Biosciences Inc
3 May 24
Entry into a Material Definitive Agreement
5:04pm
8-K
ENVB
Enveric Biosciences Inc
28 Mar 24
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:55pm
8-K
ENVB
Enveric Biosciences Inc
26 Mar 24
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023
8:00am
8-K
ENVB
Enveric Biosciences Inc
19 Mar 24
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive
7:00am
8-K
ENVB
Enveric Biosciences Inc
11 Mar 24
Entry into a Material Definitive Agreement
8:00am
8-K
3ww bimaff9c5ctc4
29 Feb 24
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds
7:00am
8-K
9f0t7qc vdhpzxk2r
21 Feb 24
Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders
8:05am
8-K
phj0ob
9 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:05am
8-K
qz7h6jk757w5
8 Jan 24
Cost Associated with Exit or Disposal Activities
4:42pm
8-K
83pwzhsjo60o022z lc
3 Jan 24
Enveric Biosciences Updates Key Data Underpinning Selection of EB-003 as Lead Drug Candidate from EVM301 Series
8:05am
8-K
e3hqwbd34uwb
29 Dec 23
Entry into a Material Definitive Agreement
4:43pm
8-K
ngj5cf 15v1vqur
28 Dec 23
Enveric to initiate preclinical development of EB-003 in 2024 in preparation for IND submission
8:05am
8-K
e0ihhm
27 Dec 23
Enveric Biosciences Reports Year End Progress for Preclinical Development of Lead Prodrug Candidate EB-373
8:05am
8-K
hy46v3pmaymc0gfd 11
5 Dec 23
Three novel neuroplastic compounds identified with plans to advance one into expedited preclinical development in 2024
8:05am
8-K
wexwrdy1
29 Nov 23
Enveric Biosciences Receives Notice of Allowance from USPTO for Development of Glycosylated Psilocybin Derivatives
8:18am
8-K
owzmp vbt8m
22 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
xe34cuqhhm2arg
13 Nov 23
Enveric Biosciences Reports Third Quarter 2023 Corporate and Financial Results
4:10pm
8-K
qanrphf 52hgfp
6 Nov 23
Entry into a Material Definitive Agreement
8:05am
8-K
wvbdm7d
2 Nov 23
Departure of Directors or Certain Officers
5:29pm
8-K
3ga93 gv6
31 Oct 23
Regulation FD Disclosure
8:05am